← Leaderboards
Isaac Hilton
Rice University
$4,035,729
Attributed
$4,035,729
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,035,729 · 4
By mechanism
R35$1,894,571 · 1
R01$968,406 · 1
R21$603,906 · 1
R56$568,846 · 1
Top collaborators
No co-investigators on record.
Most similar at Rice University
Same institution · by research overlap
- Laura Segatori$1,757,191
- Caleb Bashor$1,569,876
Others in their field
Other Emerging Leaders on “Site”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Beth Baseler · Leidos Biomedical Research, Inc.$118,180,593
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
Research focus
SiteHuman GenomeCellsResearch PersonnelTranscription FactorProteinsTechnologyGene ExpressionClustered Regularly Interspaced Short Palindromic RepeatsCell TypeProgramsInsightGene Expression RegulationChromatinPathologicEpigenomicsNucleasePost-Translational Protein ProcessingHuman DiseaseGenomeGenetic TranscriptionHistonesGenomicsCrispr/Cas Technology
Grant awards (12)
Engineering therapeutic cellular functions using robust and highly programmable extrachromosomal genetic technologies$484,203
R01 · FY2025 · EB · contact PI
Site-specific control of human gene regulation for therapeutically applicable mechanistic insights$377,111
R35 · FY2025 · GM · contact PI
Engineering therapeutic cellular functions using robust and highly programmable extrachromosomal genetic technologies$484,203
R01 · FY2024 · EB · contact PI
Site-specific control of human gene regulation for therapeutically applicable mechanistic insights$377,111
R35 · FY2024 · GM · contact PI
Site-specific control of human gene regulation for therapeutically applicable mechanistic insights$377,111
R35 · FY2023 · GM · contact PI
Engineering Therapeutic Human Immune Cells with Modular Self-contained Genetic Circuits$184,271
R21 · FY2023 · EB · contact PI
Site-specific control of human gene regulation for therapeutically applicable mechanistic insights (R35GM143532)$9,016
R35 · FY2023 · GM · contact PI
Programmable control over histone acetylation at human regulatory elements using precision epigenome editing$568,846
R56 · FY2022 · HG · contact PI
Site-specific control of human gene regulation for therapeutically applicable mechanistic insights$377,111
R35 · FY2022 · GM · contact PI
Engineering Therapeutic Human Immune Cells with Modular Self-contained Genetic Circuits$190,324
R21 · FY2022 · EB · contact PI
Site-specific control of human gene regulation for therapeutically applicable mechanistic insights$377,111
R35 · FY2021 · GM · contact PI
Engineering Therapeutic Human Immune Cells with Modular Self-contained Genetic Circuits$229,311
R21 · FY2021 · EB · contact PI